• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FERRING PHARMACEUTICALS, INC. EUFLEXXA 1% SOLUTION FOR INJECTION 10MG/1ML; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FERRING PHARMACEUTICALS, INC. EUFLEXXA 1% SOLUTION FOR INJECTION 10MG/1ML; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Urticaria (2278)
Event Date 02/27/2020
Event Type  Injury  
Event Description
Patient called in stating that she has been having hives for an extended time 1 to 1.5 years, she has been using euflexxa with positive results and they are trying to rule out potential causes for patient¿s hives.She reports she has an egg and soy allergy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA 1% SOLUTION FOR INJECTION 10MG/1ML
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
FERRING PHARMACEUTICALS, INC.
MDR Report Key9775243
MDR Text Key181829318
Report NumberMW5093431
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 02/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/28/2020
Patient Sequence Number1
Patient Age63 YR
-
-